Literature DB >> 3033866

Signet-ring cell carcinoma of bladder. Evaluation of three cases with review of literature.

N DeFillipo, R Blute, L A Klein.   

Abstract

Three cases of adenocarcinoma involving the bladder and consisting mainly of signet-ring-shaped cells are presented. Each case represents a different form that the lesion may take, and these forms are compared. This unusual neoplasm has a worse prognosis than transitional cell carcinoma of the bladder, possibly because of factors that lead to delays in management. Radiation therapy is ineffective, and the results of treatment with segmental resection of the involved area of the bladder are equivalent to those of total cystectomy.

Entities:  

Mesh:

Year:  1987        PMID: 3033866     DOI: 10.1016/0090-4295(87)90032-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Primary adenocarcinoma, signet-ring, and transitional cell carcinoma of the bladder with penile metastasis.

Authors:  R A Allen; H L Bumpers; A P Kennedy; S Parsh; D L Mobley; E L Hoover
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

2.  Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Med Oncol       Date:  2011-11-26       Impact factor: 3.064

3.  Increased frequency and nocturia in a middle aged male may not always be due to benign prostatic hypertrophy: a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-09-15

4.  Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-10-27

5.  Primary signet-ring cell carcinoma of the colorectum.

Authors:  Birgit Bittorf; Susanne Merkel; Klaus E Matzel; Axel Wein; Arno Dimmler; Werner Hohenberger
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.